BioLineRx Ltd. American Depositary Shares (BLRX)
Stock · NASDAQ · Health Care
$2.01as of 10/16/2026
Price chart
Active signals
BLRX Signal Track Record
How signals performed across all stocks →What BLRX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 22 | +1.5% | 50% | September 30, 2026 |
| Bollinger Band Breakout | 22 | -3.7% | 41% | August 19, 2026 |
| Bollinger Band BreakdownActive now | 18 | -10.9% | 33% | October 7, 2026 |
| 200-Day Moving Average TouchActive now | 9 | -12.3% | 33% | August 19, 2026 |
| Any 20-session window (baseline) | -6.1% | 35% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About BLRX
BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 20
- Website
- www.biolinerx.com/
Fundamentals
- 1-day range
- $1.99$2.3
- Market cap
- $12.14M
- P/E (trailing)
- Infinity
- P/E (forward)
- -0.80
- EPS (trailing)
- $-0.00
- Dividend yield
- —
- Beta
- 0.54
- Avg. volume
- 17.3K
- Dividend pay date
- July 15, 2019
BioLineRx Ltd. American Depositary Shares Competitors
Chosen by industry and closest market cap.
- BLRXBioLineRx Ltd. American Depositary Shares$2.01▼ 1.95%Market cap $12.14MP/E Infinity$1.1$2.3
- PHIOPhio Pharmaceuticals Corp. Common Stock$0.871▼ 5.94%Market cap $12.31MP/E —$0.8127$4.19
- VTGNVistagen Therapeutics Inc. Common Stock$0.2▼ 4.76%Market cap $12.59MP/E —$0.198$5.14
- KPRXKiora Pharmaceuticals Inc. Common Stock$2.4▼ 0.41%Market cap $11.35MP/E —$1.76$2.91
- CMMBChemomab Therapeutics Ltd. American Depositary Share$1.26▼ 1.94%Market cap $12.95MP/E —$1.05$3.5
- LNAILunai Bioworks Inc. Common Stock$0.68▼ 17.68%Market cap $10.97MP/E —$0.8757$13.28
- PBMPsyence Biomedical Ltd. Common Shares$4.22▼ 2.31%Market cap $13.31MP/E —$1.92$143.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| BLRX BioLineRx Ltd. American Depositary Shares | $12.14M | Infinity | $2.01 | ▼ 1.95% | $1.1$2.3 |
| PHIO Phio Pharmaceuticals Corp. Common Stock | $12.31M | — | $0.871 | ▼ 5.94% | $0.8127$4.19 |
| VTGN Vistagen Therapeutics Inc. Common Stock | $12.59M | — | $0.2 | ▼ 4.76% | $0.198$5.14 |
| KPRX Kiora Pharmaceuticals Inc. Common Stock | $11.35M | — | $2.4 | ▼ 0.41% | $1.76$2.91 |
| CMMB Chemomab Therapeutics Ltd. American Depositary Share | $12.95M | — | $1.26 | ▼ 1.94% | $1.05$3.5 |
| LNAI Lunai Bioworks Inc. Common Stock | $10.97M | — | $0.68 | ▼ 17.68% | $0.8757$13.28 |
| PBM Psyence Biomedical Ltd. Common Shares | $13.31M | — | $4.22 | ▼ 2.31% | $1.92$143.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 29.7K
- Total value held
- $68.5K
- Institutional holders
- 13
- Unknown10.9K
- Unknown10.2K
- Unknown2.4K
- Unknown1.8K
- Unknown1.8K
- Unknown1.7K
- Unknown529
- Unknown250
- Unknown100
- Unknown26
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
BLRX featured in after-market health care stock movers
BioLineRx was highlighted in a list of health care stocks moving during Wednesday's after-market session. The stock is currently trading near its 52-week low range, with technical indicators showing oversold conditions. Analysts maintain a significantly higher average price target than the current market price.
BLRX featured in after-market health care stock movers. BioLineRx was highlighted in a list of health care stocks moving during Wednesday's after-market session. The stock is currently trading near its 52-week low range, with technical indicators showing oversold conditions. Analysts maintain a significantly higher average price target than the current market price.